{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T22:48:48Z","timestamp":1752360528834},"reference-count":14,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2023,9,18]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p> Acyclovir has an important role in the treatment of viral central nervous system (CNS) infection, especially herpes simplex virus (HSV)-1 encephalitis. It is therefore used broadly as empiric therapy for many patients who present to the hospital with symptoms of a possible neurologic infection. We sought to review our practices in acyclovir prescribing, deprescribing, and associated investigations for the clinical syndromes it treats. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p> Through a retrospective chart review, we identified patients prescribed acyclovir for a possible CNS infection upon admission to Vancouver General Hospital between January 1, 2019, and December 31, 2019. Patient demographics, signs, symptoms, and comorbidities were taken from admission consultation notes or discharge summaries; their investigations, including laboratory tests and imaging, were also recorded. The primary purpose was to describe the appropriateness of empiric acyclovir use in suspected meningoencephalitis cases. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p> Among the 108 patients treated with acyclovir, 94 patients had an indication for starting empiric treatment for encephalitis or meningitis. There was suspicion and workup for encephalitis alone in 76 patients. Among discharge diagnoses, the most common was delirium of a different identified source (18 cases), followed by unknown\/other (15 cases). There were seven patients whose CSF viral PCR test was positive for HSV or varicella-zoster virus (VZV); three of them had HSV-1 encephalitis. There were two total adverse events recorded attributed to acyclovir; both cases were of mild acute kidney injury. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p> We found that in many patients, acyclovir was not necessary or could have been stopped earlier, avoiding toxicity and drug costs. <\/jats:p><\/jats:sec>","DOI":"10.3138\/jammi-2022-0031","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T18:21:45Z","timestamp":1675794105000},"page":"125-133","source":"Crossref","is-referenced-by-count":1,"title":["A retrospective review of empiric acyclovir prescribing practices for suspected viral central nervous system infections: A single-centre study"],"prefix":"10.3138","volume":"8","author":[{"given":"JeongMin Marie","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesilia","family":"Nishi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Vancouver General Hospital, Vancouver, British Columbia, Canada"},{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Mina","family":"Grant","sequence":"additional","affiliation":[{"name":"Divisions of Medical Microbiology and Infectious Diseases, Vancouver Coastal Health, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","reference":[{"key":"r1","first-page":"1226","volume-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases","author":"Beckham JD","year":"2020","edition":"9"},{"issue":"3","key":"r2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/341405","volume":"35","author":"Raschilas F","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"2","key":"r3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/157.2.385","volume":"157","author":"Feldman S","year":"1988","journal-title":"J Infect Dis"},{"issue":"7","key":"r4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.amjmed.2015.03.001","volume":"128","author":"Gentry JL","year":"2015","journal-title":"Am J Med"},{"issue":"6","key":"r5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0272-6386(12)70234-2","volume":"20","author":"Davenport A","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"r6","unstructured":"Powell N. \u2018Unlike anything we\u2019ve seen before\u2019: Coronavirus lockdowns strain critical supply-chains in Canada. Financial Post [Internet]. 2020 Mar 28 [cited 2022 Aug 14]. Available from: https:\/\/financialpost.com\/transportation\/unlike-anything-weve-seen-before-coronavirus-lockdowns-strain-critical-supply-chains-in-canada"},{"key":"r7","unstructured":"Reports for ACYCLOVIR [Internet]. Drug Shortages Canada. 2022 [cited 2022 Aug 14]. Available from: https:\/\/www.drugshortagescanada.ca\/ingredient\/422?orderby=status&order=asc&shortage_page=2&limit=20&discontinuance_limit=10&shortage_offset=10&shortage_limit=10&allow_all_user_shortages=1"},{"issue":"3","key":"r8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.eimc.2008.05.006","volume":"27","author":"Riera-Mestre A","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"8","key":"r9","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","volume":"57","author":"Venkatesan A","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"r10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/JCM.01950-06","volume":"45","author":"Hanson KE","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"2","key":"r11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/cid\/ciu772","volume":"60","author":"Noska A","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"r12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmi.2021.05.017","volume":"28","author":"Lindstrom J","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"r13","unstructured":"Association of Medical Microbiology and Infectious Diseases Canada. Five Tests and Treatments to Question in Medical Microbiology and Infectious Diseases [Internet]. Choosing Wisely; 2021 [cited 2022 Aug 14]. Available from: https:\/\/choosingwiselycanada.org\/recommendation\/medical-microbiology\/"},{"issue":"4","key":"r14","first-page":"169","volume":"1","author":"Tyler K","year":"2004","journal-title":"Rev Neurol Dis"}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jammi.utpjournals.press\/doi\/pdf\/10.3138\/jammi-2022-0031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T21:47:42Z","timestamp":1696456062000},"score":1,"resource":{"primary":{"URL":"https:\/\/jammi.utpjournals.press\/doi\/10.3138\/jammi-2022-0031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,9,18]]}},"alternative-id":["10.3138\/jammi-2022-0031"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2022-0031","relation":{},"ISSN":["2371-0888","2371-0888"],"issn-type":[{"value":"2371-0888","type":"print"},{"value":"2371-0888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]}}}